• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.

作者信息

Shi Yu, Yu Xia, Zhao Hong, Wang Hao, Zhao Ruihong, Sheng Jifang

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Qingchun Road, No. 79, Hangzhou, 310003, China.

出版信息

Crit Care. 2020 Mar 18;24(1):108. doi: 10.1186/s13054-020-2833-7.

DOI:10.1186/s13054-020-2833-7
PMID:32188484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7081524/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62cc/7081524/0037da815e12/13054_2020_2833_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62cc/7081524/0037da815e12/13054_2020_2833_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62cc/7081524/0037da815e12/13054_2020_2833_Fig1_HTML.jpg

相似文献

1
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.宿主对重症新型冠状病毒肺炎的易感性及宿主风险评分的建立：武汉以外地区487例病例的研究结果
Crit Care. 2020 Mar 18;24(1):108. doi: 10.1186/s13054-020-2833-7.
2
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
Assessment of workers' personal vulnerability to covid-19 using 'covid-age'.使用“新冠年龄”评估工人个人对新冠病毒的易感性。
Occup Med (Lond). 2020 Oct 27;70(7):461-464. doi: 10.1093/occmed/kqaa150.
5
Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.估算 2020 年 1-2 月中国新冠肺炎死亡风险。
Emerg Infect Dis. 2020 Jun;26(6):1251-1256. doi: 10.3201/eid2606.200233. Epub 2020 Jun 17.
6
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.中国湖南两中心回顾性队列研究 213 例病例：武汉以外地区 COVID-19 严重程度的临床特征和危险因素。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963035. doi: 10.1177/1753466620963035.
7
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者疾病严重程度、无改善和死亡率的危险因素。
Clin Microbiol Infect. 2020 Jun;26(6):767-772. doi: 10.1016/j.cmi.2020.04.012. Epub 2020 Apr 15.
8
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率：一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
9
Death from Covid-19 of 23 Health Care Workers in China.中国23名医护人员死于新冠病毒。
N Engl J Med. 2020 Jun 4;382(23):2267-2268. doi: 10.1056/NEJMc2005696. Epub 2020 Apr 15.
10
Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China.中国新冠肺炎死亡患者的临床特征。
JAMA Netw Open. 2020 Apr 1;3(4):e205619. doi: 10.1001/jamanetworkopen.2020.5619.

引用本文的文献

1
A model based on PT-INR and age serves as a promising predictor for evaluating mortality risk in patients with SARS-CoV-2 infection.基于国际标准化比值（PT-INR）和年龄的模型可作为评估2019冠状病毒病（SARS-CoV-2）感染患者死亡风险的一种有前景的预测指标。
Front Cell Infect Microbiol. 2025 Apr 3;15:1499154. doi: 10.3389/fcimb.2025.1499154. eCollection 2025.
2
Predictors of developing severe COVID-19 among hospitalized patients: a retrospective study.住院患者中发生重症 COVID-19 的预测因素：一项回顾性研究。
Front Med (Lausanne). 2025 Jan 14;11:1494302. doi: 10.3389/fmed.2024.1494302. eCollection 2024.
3
An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies.

本文引用的文献

1
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.一组在中国武汉以外地区感染 2019 年新型冠状病毒（SARS-CoV-2）的患者的临床特征：回顾性病例系列。
BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606.
2
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
深入洞察新冠病毒相关心血管疾病的临床、细胞和分子因素，以确定新型疾病生物标志物、药物靶点和临床管理策略。
Arch Microbiol Immunol. 2024;8(3):290-308. doi: 10.26502/ami.936500177. Epub 2024 Jul 19.
4
Clinical characteristics of SARS-CoV-2 Omicron pneumonia in immunocompromised and immunocompetent patients: A retrospective cohort study.免疫功能低下和免疫功能正常患者的新型冠状病毒奥密克戎肺炎临床特征：一项回顾性队列研究
Heliyon. 2024 Oct 9;10(20):e39044. doi: 10.1016/j.heliyon.2024.e39044. eCollection 2024 Oct 30.
5
A tri-light warning system for hospitalized COVID-19 patients: Credibility-based risk stratification for future pandemic preparedness.用于新冠肺炎住院患者的三灯预警系统：基于可信度的风险分层以应对未来大流行防范
Eur J Radiol Open. 2024 Oct 17;13:100603. doi: 10.1016/j.ejro.2024.100603. eCollection 2024 Dec.
6
Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study.恢复期 COVID-19 患者一年随访时血压变异性评估：一项回顾性队列研究。
BMC Cardiovasc Disord. 2024 May 7;24(1):240. doi: 10.1186/s12872-024-03916-w.
7
Correlation of clinical, laboratory, and short-term outcomes of immunocompromised and immunocompetent COVID-19 patients with semi-quantitative chest CT score findings: A case-control study.免疫抑制和免疫功能正常的 COVID-19 患者的临床、实验室和短期结局与半定量胸部 CT 评分结果的相关性：一项病例对照研究。
Immun Inflamm Dis. 2024 Apr;12(4):e1239. doi: 10.1002/iid3.1239.
8
The Disconnect Between Development and Intended Use of Clinical Prediction Models for Covid-19: A Systematic Review and Real-World Data Illustration.新型冠状病毒肺炎临床预测模型的开发与预期用途之间的脱节：系统评价与真实世界数据例证
Front Epidemiol. 2022 Jun 27;2:899589. doi: 10.3389/fepid.2022.899589. eCollection 2022.
9
Demographic study of patients' mortality rate before and after the COVID-19 outbreak: A cross-sectional study.新冠疫情爆发前后患者死亡率的人口统计学研究：一项横断面研究。
Health Sci Rep. 2024 Feb 8;7(2):e1845. doi: 10.1002/hsr2.1845. eCollection 2024 Feb.
10
Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach.天然黄酮类化合物对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突受体结合域中选定的奥密克戎（B.1.19）突变的抑制潜力：一种分子建模方法。
J Biomol Struct Dyn. 2025 Feb;43(2):1068-1082. doi: 10.1080/07391102.2023.2291165. Epub 2023 Dec 19.
中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
4
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.